Pharma Options Recap
We cast a wide net yesterday with a trio of options ideas in the pharma space related to the reversal of the Trump administration’s position on drug rebate policy. The sector was bustling with activity in the premarket, and two out of our three ideas bore fruit.
Here were the total possible gains available to daytraders for the session:
Cigna Corp. CI $167.50-175 Calls
$167.50 Calls – Range: 10.04-17.00 – Max Gain: 52%
$170 Calls – Range: 10.02-14.30 – Max Gain: 58%
$175 Calls – Range: 1.10-1.80 – Max Gain: 64%
United Health Corp. UNH $250-255 Calls
$250 Calls – Range: 2.48-11.09 – Max Gain: 52%
$252.50 Calls – Range: 2.50-8.70 – Max Gain: 58%
$255 Calls – Range: .99-6.20 – Max Gain: 70%
In addition to these plays, we’ll continue to keep an eye on the CVS Health Corp. CVS Weekly $57-58.50 Calls through the end of the day.
SPDR S&P500 (ETF) SPY $299-300 Calls
Taronis Technologies, Inc. TRNX
On Monday morning, we highlighted TRNX as a prime bottom-bounce candidate, and we’d like to wrap up the week by going over the solid swings which we subsequently observed in the stock.
On Monday itself, our choice in timing on calling this play was affirmed as we saw a solid 52% run from .25-.38. This was followed by a pullback to a low of .1832 the following day, and over the course of the rest of the week, TRNX has stair-stepped its way back up to .34, which represents an additional 86% swing.
MLNT, CLVS, NVCN, APLS, SFIX, ADXS, INFY, OBLN